In addition to therapeutic vaccines for solid tumors, Orbis scientists are developing a cancer vaccine for blood borne cancers which would require a device to "debulk" a patient's blood to remove tumor tissue. 

Small scale efforts have been successful and Orbis is currently testing this approach in live cancer cell models.